FLUOROPHARMA MEDICAL, INC. - FORM 10-K - EX-23.1 - CONSENTS OF EXPERTS AND COUNSEL - March 31, 2017

Attached files

file filename
EX-32.2 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - FLUOROPHARMA MEDICAL, INC.ex32-2.htm
EX-32.1 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - FLUOROPHARMA MEDICAL, INC.ex32-1.htm
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - FLUOROPHARMA MEDICAL, INC.ex31-2.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - FLUOROPHARMA MEDICAL, INC.ex31-1.htm
10-K - FORM 10-K - FLUOROPHARMA MEDICAL, INC.fpmi10k_dec312016.htm
 
Exhibit 23.1
 
Consent of Independent Registered Public Accounting Firm
 
We consent to the incorporation by reference in Registration Statement (No. 333-185648) on Form S-8 of FluoroPharma Medical, Inc. of our report dated March 31, 2017, relating to our audit of the consolidated financial statements, which appear in this Annual Report on Form 10-K of FluoroPharma Medical, Inc. for the year ended December 31, 2016.  Our report dated March 31, 2017, relating to the consolidated financial statements includes an emphasis paragraph relating to an uncertainty as to the Company's ability to continue as a going concern.
 
 
/s/ Wolf & Company, P.C.
 
Boston, Massachusetts
March 31, 2017
 
 

FLUOROPHARMA MEDICAL, INC. Reports